✦ LIBER ✦

Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma

✍ Scribed by van de Donk, N W C J; Kröger, N; Hegenbart, U; Corradini, P; Miguel, J F San; Goldschmidt, H; Perez-Simon, J A; Zijlmans, M; Raymakers, R A; Montefusco, V

Book ID: 110015022
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 141 KB
Volume: 37
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1705393

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Donor lymphocyte infusion post-non-myelo

Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease

✍ Nagler, A; Ackerstein, A; Kapelushnik, J; Or, R; Naparstek, E; Slavin, S 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 41 KB

Donor cell-derived acute lymphocytic leu

Donor cell-derived acute lymphocytic leukemia after allogeneic stem cell transplantation for multiple myeloma

✍ Natsue Igarashi; Takaaki Chou; Takayuki Hirose; Yousuke Imai; Takuro Ishiguro; K 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 227 KB

Outcome and long-term follow-up of allor

Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT)

✍ Michallet, A S; Nicolini, F; Fürst, S; Le, Q H; Dubois, V; Hayette, S; Bourgeot, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 346 KB

Extramedullary relapses after allogeneic

Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome

✍ Minnema, M C; van de Donk, N W C J; Zweegman, S; Hegenbart, U; Schonland, S; Ray 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB

Myeloablative allogeneic stem cell trans

Myeloablative allogeneic stem cell transplantation for advanced stage multiple myeloma: very long-term follow up of a single center experience

✍ G. A. KENNEDY; J. BUTLER; J. MORTON; G. HILL; R. WESTERN; J. CUMMINGS; R. ALLISO 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Prognostic factors for patients with acu

Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation

✍ Thorsten Graef; Matthias Vaupel; Roland Fenk; Leilani Ruf; Fabian Zohren; Ulrich 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 1 views

## Abstract In this uni‐centre retrospective study, we studied 120 adults with acute myeloid leukaemia (AML) (__n__ = 88) and myelodysplastic syndrome (MDS) (__n__ = 32) who received first allogeneic HSCT to determine prognostic factors which are correlated with the outcome after myeloablative (MA)